George Freeman outlines Government commitment to double spending on apprenticeships as crucial to providing opportunity and social mobility in areas too often left behind in the past.
Speaking in reply to a debate on access to specialist neuromuscular care and treatments, George Freeman urges the drug manufacturers to work with NHS England to speed up access to specialist drugs which are available elsewhere in Europe.
George Freeman outlines opportunities for the UK to use our leadership in genomics and informatics to better understand patients’ genetic predisposition to different diseases and to respond to different drugs. He commends the work of the Cystic Fibrosis Trust and other charities who are at the forefront of patient-led innovation that is greatly contributing to the work on accelerating the commissioning of rare disease treatments which will benefit their patients.
George Freeman highlights the progress being made by the world-leading Genomics England project which is sequencing 100,000 entire genomes of NHS patients to establish NHS and UK leadership in the fast-emerging field of genomic medicine.